Mark Hutchens
Sports Medicine · Austin, TXNPI 1467461293
Payments from drug & device makers
Across 1,486 payments — averaging $1702.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi Pasteur Inc.$1.6M
- GSK$396K
- Modernatx, Inc.$283K
- Janssen Research & Development, LLC$218K
- Merck$11K
- Gilead$30
- plus $22 from 1 others
What the payments were for
- Food & beverage$52100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi Pasteur Inc. | 108 | $1,622,693 |
| GSK | 33 | $396,276 |
| Modernatx, Inc. | 1,317 | $282,693 |
| Janssen Research & Development, LLC | 24 | $218,040 |
| Merck | 1 | $10,500 |
| Gilead | 2 | $30 |
| Abbott | 1 | $22 |
How this compares
$2,530,254 in reported general payments places this provider in the 95th percentile of 437 sports medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 156 | $47,211 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 187 | $39,062 |
| Boostrix TdapDiphth,pertuss(Acell),tet Vac | 30 | $1,967 |
| VaqtaHepatitis A Virus Vaccine/Pf | 13 | $1,249 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKShingrix | $396,276 | $39,062187 claims |
| MerckVaqta | $10,500 | $1,24913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 437 sports medicine providers in Texas.
Other sports medicine in Austin
- Timothy VachrisAustin$5.7M
- John McDonaldAustin$499K
- Douglas ElenzAustin$313K
- Greg WestmorelandAustin$51K
- Darryl ThomasAustin$37K
- Thomas DeberardinoSan Antonio$3.5M
- Robert ScheinbergDallas$2.2M
- Marc LabbeThe Woodlands$2M
- Walter LoweHouston$1.4M
- Reed BartzSunnyvale$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.